Xinyuan Real Estate: Record 2Q Sales Balanced by High Interest & Tax

Posted on by John Sheehy

Highlights from Xinyuan's recently reported 2Q17 results and Conference Call Record quarterly contract sales of $732mm SG&A expense declined to 9.9% of revenue (vs 11.4% for FY16) Unusually high interest expense of $20.2mm Effective tax rate of 56% Book Value rose to $14.13/ADS Conservative land acquisition budget of 5-7Bn RMB No full-year financial guidance Achieved … Continue reading Xinyuan Real Estate: Record 2Q Sales Balanced by High Interest & Tax

Ossen Innovation Acquisition Target Valued at $40.6mm in March, Equals $1.37/ADS

Posted on by John Sheehy

In conjunction with sale of its steel business to its Chairman for $0, Ossen proposes to acquire America-Asia Diabetes research Foundation (AADRF or San Meditech).  A March 2017 private placement by AADRF provides a realistic benchmark for the fair value of the business (source Ossen proxy page 202). Proceeds of $6,000,000 were received from sale … Continue reading Ossen Innovation Acquisition Target Valued at $40.6mm in March, Equals $1.37/ADS

Ossen Innovation Filed the Proxy Statement for its Chairman’s $0 Buyout Offer

Posted on by John Sheehy

This will update my July 26 Article (LINK) with information disclosed in Ossen's Proxy Statement (LINK) for the shareholder meeting scheduled for September 5, 2017.  Key points: Ossen Chairman Liang Tang will abstain from voting his shares at the meeting.  His $0 acquisition of Ossen's business will require approval by an affirmative majority of disinterested … Continue reading Ossen Innovation Filed the Proxy Statement for its Chairman’s $0 Buyout Offer